The ABPI’s Dr Richard Torbett, speaking to the International Trade Committee, said the COVID-19 pandemic highlights the need for a globalised drug supply chain.
A key element of the U.S. Food and Drug Administration's (FDA) mission is focused on helping to ensure that all products we regulate, including drugs available to consumers, are safe and of high quality.